Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Acorda Therapeutics, Inc. - Acorda Therapeutics Resubmits New Drug Application for Fampridine-SR for Improvement of Walking Ability in People with Multiple Sclerosis
Bextra and Celebrex Claims Administrator - $89 Million Proposed Class Action Settlement Provides Consumers and Insurers With Money Back for Celebrex and Bextra Purchases and Reimbursements
Books - Larry's Kidney Destined to Become The Next Big Thing
Bristol-Myers Squibb Company - U.S. Food and Drug Administration Extends Review Timeline for ONGLYZA™ saxagliptin New Drug Application
Drug Development - Watson Confirms Filing of Abbreviated New Drug Application for Generic Enablex(R)
Influenza - Luminex Confirms Effectiveness of Xtag® Respiratory Viral Panel for Swine Flu Surveillance
Make Our Food Safe Campaign - Foodborne Illness Victims Mark President Obama's First 100 Days By Calling for Permanent Fix To Food Safety System
Pediatrics - New Federal Legislation Targets Toxic Chemicals in Baby Bath Products
Pharmaceuticals - nanoTox Chief Scientific Officer, Dr. David W. Hobson, to Speak on Nanotech Policy, Regulation and Product Safety at NSTI Nanotech
ReportLinker - Examine the Botanical and Plant-Derived Drugs: Global Markets
Sidley Austin LLP - Former Counsel from the House Energy and Commerce Committee, Peter M. Goodloe, Joins Sidley Austin LLP
U.S. Department of Justice - Ali Al-Marri Pleads Guilty to Conspiracy to Provide Material Support to Al-Qaeda
Abiomed - Abiomed Receives FDA 510k Clearance for Impella® 5.0 and Impella® LD
Advaxis, Inc. - Advaxis Applies for Approximately $1.0 Million Worth of Grants from the National Institute of Health
Adverse Drug Reactions - New findings from A.M. Hochberg and co-authors in the area of adverse drug reactions published
Adverse Drug Reactions - Research from University of Arizona in the area of adverse drug reactions described
Agilent Technologies Inc. - TRADE NEWS: Agilent Technologies Introduces Most Powerful, Most Sensitive, Most Flexible Liquid Chromatography System Available
Angiology - FDA has Granted HUD (Humanitarian Use Device) Designation to ITGI's Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforatio
Anterior Uveitis - Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Anthrax Vaccines - PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
Antibiotics - SkinWear(TM) Hand Cleaner & Sanitizer Kills Germs That May Cause Swine Flu, Protects Against Germs for Up to Eight Hours
Antigenics Inc. - FDA Grants Orphan Drug Designation to Oncophage for the Treatment of Glioma
Cancer - NCCN Oncology Research Program Celebrates 10th Anniversary by Closing in on $20 Million in Funding; Program Expands Into Developmental Therapies
Cancer - ProCure and IBA Announce FDA Clearance of a New Generation Patient Positioning System
Cancer - US Oncology Commends Governor Sebelius' Confirmation as U.S. Secretary of Health and Human Services
Cancer Vaccines - Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
Cougar Biotechnology, Inc. - Cougar Biotechnology Initiates Phase III Trial of CB7630 Abiraterone Acetate in Chemotherapy-Naive Castration-Resistant Prostate Cancer Patients
Cystic Fibrosis - Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG
Dermatology - American Academy of Dermatology Responds to FDA Decision Regarding Botulinum Toxin Products
Dupuytren's Disease - BioSpecifics Technologies Corp. Announces FDA Acceptance of Biologics License Application With Priority Review for XIAFLEX(TM) for the Treatment of Dupuytren's Disease
DxNA - DxNA to Use its Rapid Detection Platform to Simplify Testing for Swine Flu (H1N1 Virus)
Gene Therapy - Reports outline gene therapy study results from Yale University
HIV/AIDS - ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
HIV/AIDS Therapy - Research on HIV/AIDS therapy reported by scientists at Northwestern University
Incontinence - New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB RIGHTPARE
Influenza - Public Health Laboratories To Assume Primary Responsibility for Confirmatory Testing of Swine Flu
InnoCentive, Inc. - Prize4Life Awards Prizes for ALS Biomarker Challenge to InnoCentive Solvers
Integrase - New integrase study findings recently were published by O. Delelis and co-researchers
INVO Bioscience, Inc. - INVO Centers in Operation in the Developing Nations Indicate Progress for INVO Bioscience, Inc.
Ipsen - Ipsen’s First Quarter 2009 Sales and Financial Outlook for the Full Year
ITGI Medical Ltd - FDA has Granted HUD Humanitarian Use Device Designation to ITGI's Pericardium Covered Stents, Over and Under and Aneugraft, for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Graft
Neuralgia - NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
Obesity - Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program
Oceana Therapeutics, LLC. - Q-Med AB and Oceana Therapeutics enter into agreements for worldwide rights to Hospital Healthcare Products
Oculus Innovative Sciences, Inc. - Oculus Innovative Sciences Presents Business Update Prior to Financial West Investor Conference
Oxford Nanopore - Professor Hagan Bayley Named Chemistry World Entrepreneur of the Year 2008
Oxygen Biotherapeutics, Inc. - Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
Patents - LANAP Inventors Call ADA's Laser Position Statement Flawed
Pediatric Vaccines - Swine Flu Outbreak Illustrates Problems in Vaccine Development
Pegasus Biologics, Inc. - Surgeons Utilize Collagen Bioscaffolds to Treat Diabetic Ulcers, Save Limbs
Pharmaceuticals - Hector Garcia Joins Particle Sciences as Director of Quality Assurance
Pharmaceuticals - Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
Poisoning - Studies from N.H. Beyer and colleagues provide new data on poisoning
PPD, Inc. - PPD Reports First Quarter 2009 Financial Results; Updates 2009 Financial Guidance
Prostate Cancer - Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
Prostate Cancer - Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
Prostate Cancer - Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis
Prostate Cancer - OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
pSivida Corp. - pSivida Corp. Technology Featured in Multiple Abstracts at ARVO Meeting
Public Health - Data from D.C. Taylorrobinson and colleagues advance knowledge in public health
QPharma, Inc. - QPharma Warehouses Receive Accreditation from National Association of Boards of Pharmacy NABP
Respiratory Disease - BioMarck Pharmaceuticals Escalates to the Middle Dose of Its Phase 2 Study, and Closes $6.3 Million Series C Financing
Respiratory Disease - K-State Researcher Finds That the 1918 Spanish Flu Virus Can Infect Swine and Resulted in Current Lineage of H1N1 Swine Influenza Viruses
Revolutions Medical Corporation - Revolutions Medical Acquires Exclusive Rights to License FDA Approved Breast Biopsy Localization System
Sanofi-aventis - Sanofi-aventis Announces Good First-quarter 2009 Performance
Sciele Pharma, Inc. - Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD
Sciele Pharma, Inc. - Sciele Pharma and Plethora Solutions Announce That PSD502 Demonstrates Substantial Benefit in the Treatment of Premature Ejaculation
Seattle Genetics, Inc. - Seattle Genetics Reports Product Development Progress and First Quarter 2009 Financial Results
Sepracor Inc. - Sepracor Reports Preliminary Phase III Study Results for OMNARIS® HFA Nasal Aerosol in Seasonal Allergic Rhinitis
Sickle Cell Anemia - Sickle Cell Treatment Developed at LA BioMed Approved for Phase 3 Clinical Trial
Skyscanner - Travellers to Mexico so far Undeterred by Swine Flu Outbreak
Smiths Detection - Smiths Detection Announces Global Release of New Personal Chemical Alarm Device
Talecris Biotherapeutics, Inc. - New Publication of Landmark Study Demonstrates Gamunex® Improves Health-Related Quality of Life in Patients with CIDP
Teva Pharmaceutical Industries Ltd. - Teva to Present New Data on Its Innovative Therapies for Multiple Sclerosis and Parkinson’s Disease at the Upcoming 2009 American Academy of Neurology Annual Meeting
Tissue Engineering - New findings from University of Wisconsin in the area of tissue engineering described
Tissue Engineering - Researchers at Harvard University, Medical Department publish new data on tissue engineering
Tuberculosis - Scientists at University of Foggia discuss research in tuberculosis
Tunstall Healthcare A/S - Tunstall Receives FDA 510(k) Clearance to Market Wireless Telehealth Monitor With Built-in GSM/GPRS Mobile Phone Technology in USA
Type 2 Diabetes - Studies from M.J. Lage and co-researchers in the area of type 2 diabetes published
